SP2
Basic information
Region (hg38): 17:47896150-47928957
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 2 | 0 |
Variants in SP2
This is a list of pathogenic ClinVar variants found in the SP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-47916235-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
17-47916238-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
17-47916420-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
17-47916459-A-G | not specified | Uncertain significance (Sep 15, 2021) | ||
17-47916570-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
17-47916631-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
17-47916637-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
17-47916650-C-T | Likely benign (Jun 01, 2022) | |||
17-47916660-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
17-47916672-G-C | not specified | Uncertain significance (Jun 03, 2022) | ||
17-47916693-G-A | not specified | Uncertain significance (Dec 01, 2023) | ||
17-47916703-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
17-47916747-G-A | not specified | Uncertain significance (May 18, 2022) | ||
17-47916761-G-C | not specified | Uncertain significance (Nov 27, 2023) | ||
17-47916784-C-A | not specified | Uncertain significance (Apr 17, 2023) | ||
17-47916894-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
17-47916898-A-G | not specified | Uncertain significance (Nov 30, 2022) | ||
17-47916901-T-A | not specified | Uncertain significance (Nov 23, 2021) | ||
17-47916948-G-A | not specified | Uncertain significance (Nov 07, 2023) | ||
17-47917025-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
17-47917036-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
17-47922975-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
17-47922988-G-C | not specified | Uncertain significance (May 09, 2023) | ||
17-47923080-A-G | not specified | Uncertain significance (Apr 19, 2024) | ||
17-47923247-G-A | not specified | Uncertain significance (Mar 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SP2 | protein_coding | protein_coding | ENST00000376741 | 7 | 32808 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00279 | 124803 | 0 | 2 | 124805 | 0.00000801 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.37 | 247 | 376 | 0.656 | 0.0000227 | 3962 |
Missense in Polyphen | 50 | 102.59 | 0.4874 | 1128 | ||
Synonymous | -0.715 | 172 | 160 | 1.07 | 0.0000103 | 1321 |
Loss of Function | 4.12 | 1 | 21.7 | 0.0461 | 0.00000112 | 223 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.00000885 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to GC box promoters elements and selectively activates mRNA synthesis from genes that contain functional recognition sites.;
Recessive Scores
- pRec
- 0.287
Intolerance Scores
- loftool
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.28
Haploinsufficiency Scores
- pHI
- 0.951
- hipred
- Y
- hipred_score
- 0.617
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sp2
- Phenotype
- growth/size/body region phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Zebrafish Information Network
- Gene name
- sp2
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;immune response;multicellular organism growth
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;histone deacetylase binding;metal ion binding